Skip to main content

Advertisement

SpringerLink
Log in

An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Few data are available to assess the efficacy of rehabilitative interventions in systemic sclerosis (SSc). We refer here the results of an individualized rehabilitation program in 16 patients with SSc. In particular, when possible, the number of patients who achieved a minimal clinically important difference (MCID) was determined. Results were evaluated taking advantage of the development of validated questionnaires and tests to assess quality of life (QOL) and disability in SSc. At the end of a period of 4 months of observation, 69% and 62% of patients reported an improvement of the physical and mental components of the SF-36 higher than the MCID (as established in other rheumatic conditions). Analogously, an improvement of the impact of respiratory disease on patients’ QOL, as assessed by the Saint George’s Respiratory Questionnaire, was perceived by 67% of them. These results might be explained by better exercise tolerance, which was suggested by the significant reduction of the heart rate and of a visual analogue scale for dyspnoea at the end of the 6-min walking test. Finally, a statistically significant improvement of hand mobility, as assessed by the hand mobility in scleroderma test was obtained. This study suggests that a significant proportion of patients with SSc experience an improvement in their perception of QOL, a better exercise tolerance, and a better hand mobility after a rehabilitation program consisting by a 2-week period of daily individual 30-min sessions as outpatient, followed by at-home exercise program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557–567

    Article  PubMed  CAS  Google Scholar 

  2. Seibold JR (2005) Scleroderma. In: Harris ED Jr, Budd RC, Firestein GS et al (eds) Kelley’s textbook of rheumatology. 7th edn. Elsevier, Philadelphia, pp 1279–1308

    Google Scholar 

  3. Khanna D, Ahmed M, Furst DE et al (2007) Health values of patients with systemic sclerosis. Arthritis Rheum 57:86–93

    Article  PubMed  Google Scholar 

  4. Casale R, Buonocore M, Matucci-Cerinic M (1997) Systemic Sclerosis (Sclerodermia): an integrated challenge in rehabilitation. Arch Phys Med Rehabil 78:767–773

    Article  PubMed  CAS  Google Scholar 

  5. Mouthon L, Berezné A, Poiraudeau S, Guillevin L (2006) Therapeutic management of systemic sclerosis. Presse Med 35:1975–1982, [French]

    Article  PubMed  Google Scholar 

  6. Khanna D, Lovell DJ, Giannini E et al (2008) Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 67:703–709

    Article  PubMed  CAS  Google Scholar 

  7. Hays RD, Woolley JM (2000) The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 18:419–423

    Article  PubMed  CAS  Google Scholar 

  8. LeRoy EC, Black C, Fleischmayer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208

    PubMed  CAS  Google Scholar 

  9. Airò P, Danieli E, Rossi M et al (2007) Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase. Clin Exp Rheumatol 25:293–296

    PubMed  Google Scholar 

  10. Airò P, Rossi M, Scarsi M, Danieli E, Grottolo A, Zambruni A (2007) Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group. Clin Exp Rheumatol 25:722–727

    PubMed  Google Scholar 

  11. Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire to determine physical disability in systemic sclerosis. Arthritis Care Res 4:27–31

    Article  PubMed  CAS  Google Scholar 

  12. Ranza R, Marchesoni A, Calori G et al (1993) The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 11:123–128

    PubMed  CAS  Google Scholar 

  13. Khanna D, Furst DE, Hays RD et al (2006) Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 65:1325–1329

    Article  PubMed  CAS  Google Scholar 

  14. Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  15. Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036

    Article  PubMed  CAS  Google Scholar 

  16. Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F (2002) Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire. Reumatismo 54:122–127, [Italian]

    PubMed  CAS  Google Scholar 

  17. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr (2000) Determining minimally important changes in generic and disease- specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 7:1478–1487

    Article  Google Scholar 

  18. Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R (2007) Validity of the Saint George’s Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to Systemic Sclerosis. Rheumatology 46:296–301

    Article  PubMed  CAS  Google Scholar 

  19. Carone M, Bertolotti G, Anchisi F et al (1999) The St. George’s Respiratory Questionnaire (SGRQ): Italian version. Rassegna di Patologia dell’Apparato Respiratorio 14:31–37

    Google Scholar 

  20. Jones PW, Quirk FH, Baveystock CM (1991) The St George’s Respiratory Questionnaire. Respir Med 85:25–31

    Article  PubMed  Google Scholar 

  21. Sandqvist G, Eklund M (2000) Validity of HAMIS: A test of Hand Mobility in Scleroderma. Arthritis Care Res 13:382–387

    Article  PubMed  CAS  Google Scholar 

  22. American Thoracic Society (2002) Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117

    Google Scholar 

  23. Redelmeier DA, Bayoumi AM, Goldstein RS et al (1997) Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155:1278–1282

    PubMed  CAS  Google Scholar 

  24. Mahler DA, Horowitz MB (1994) Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exe 20:1078–1081

    Google Scholar 

  25. De Torres JP, Pinto-Plata V, Ingenito E et al (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121:1092–1098

    Article  PubMed  Google Scholar 

  26. Mahler DA, Horowitz MB (1994) Clinical evaluation of exertional dyspnea. Clin Chest Med 15:259–269

    PubMed  CAS  Google Scholar 

  27. Cotes JE, Chinn DJ, Roca J, Quanjer PH, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J (suppl) 16:41–52

    CAS  Google Scholar 

  28. Quanjer PH, Tammerling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1994) Lung volumes and forced ventilatory flows. Rev Mal Respir 11:5–40

    PubMed  Google Scholar 

  29. Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1277–1280

    Google Scholar 

  30. Alexanderson H, Stenstrom CH, Jenner G, Lundberg I (2000) The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 29:295–301

    Article  PubMed  CAS  Google Scholar 

  31. de Carvalho MRP, Sato EI, Tebexfreni AS et al (2005) Effects of a supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 53:838–844

    Article  PubMed  Google Scholar 

  32. Sandqvist G, Akesson A, Eklund M (2004) Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil 26:981–987

    Article  PubMed  Google Scholar 

  33. Naylor PW, Douglass CW, Mix E (1984) The nonsurgical treatment of microstomia in scleroderma: A pilot study. Oral Surg Oral Med Oral Pathol 57:508–511

    Article  PubMed  CAS  Google Scholar 

  34. Danieli E, Airò P, Bettoni L et al (2005) Health-Related quality of life measured by the short form 36 (SF-36) in Systemic Sclerosis: Correlations With indexes of Disease Activity and severity, disability, and depressive symptoms. Clin Reumatol 24:48–54

    Article  Google Scholar 

  35. Airo’ P, Tabaglio E, Frassi M, Scarsi M, Danieli E, Rossi M (2007) Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners. Clin Exp Rheumatol 25:807–809

    Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Rheumatology and Clinical Immunology Service, Spedali Civili di Brescia and University of Brescia, piazzale Spedali Civili, 1, 25123, Brescia, Italy

    Anna Frigè, Mirko Scarsi, Elisabetta Danieli & Paolo Airo

  2. Rehabilitation Unit, Casa di Cura “Città di Brescia”, Brescia, Italy

    Chiara M. Antonioli, Giovanni Bua, Katia Prandini, Sara Radici & Andrea Malvicini

Authors
  1. Chiara M. Antonioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Bua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Frigè
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katia Prandini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sara Radici
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mirko Scarsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elisabetta Danieli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrea Malvicini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paolo Airo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Airo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antonioli, C.M., Bua, G., Frigè, A. et al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol 28, 159–165 (2009). https://doi.org/10.1007/s10067-008-1006-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1006-x

Keywords

Search

Navigation